BioSpace News Archive

Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and full year ended December 31, 2019

CareDx, Inc. announced that Peter Maag, Chief Executive Officer, Michael Bell, Chief Financial Officer, and Reg Seeto, President and Chief Business Officer will be participating in two upcoming investor conferences.

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the company’s support for Rare Disease Day 2020 and the effort to help more people learn about the impact of rare diseases on patients, their families and their caregivers

Remedy solves patients’ need for convenient, simplified, efficient health services

Cepheid and Sherlock Biosciences today announced a research collaboration between the two companies to explore the development of new cutting-edge molecular diagnostic tests. Leveraging Sherlock Biosciences’ engineering biology platform, SHERLOCK™, a CRISPR-based technology that can identify virtually any genetic target, new tests could be designed to run on Cepheid’s GeneXpert® Systems.

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) is joining forces with 30 million healthcare advocates around the world for the 13th Annual Rare Disease Day®, an awareness day dedicated to elevating public understanding of rare diseases and calling attention to the special challenges people living with rare diseases face.

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer, non-addictive therapeutics for pain and inflammation, is pleased to announce that the last patient has been enrolled and is on treatment in the Phase 2B dose-ranging, efficacy study of Antibe’s lead drug, ATB-346.

Encompass Health Corp. announced it has purchased land near the 4900 block of 12th Ave. in Pensacola, Florida with plans to build a 40-bed inpatient rehabilitation hospital to serve patients recovering from debilitating illnesses and injuries.

Expanded long-term partnership to increase Leica Microsystems’ ability to serve strategic accounts and accelerate growth

Acura Pharmaceuticals, Inc. (OTC: ACUR), , announced today financial results for the three and nine months ended September 30, 2019.